BE COOL PHARMACEUTICS, LLC
Biotech · Private
CHA/8-SPT combination therapeutic—a dual-molecule system combining 6N cyclohexyl adenosine (CHA) with 8-(p-Sulfophenyl)theophylline (8-SPT) to induce controlled hypothermia, suppress shivering and sei
- Grants
- $457K
- 3 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201720182019
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Development of the first thermolytic to suppress shivering and seizure | $298,871 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of the first thermolytic to suppress shivering and seizure | $103,435 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of the first thermolytic to suppress shivering and seizure | $55,000 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2211 | TECTARIA BIO LLC | — | — |
| 2212 | PARATEK PHARMACEUTICALS INC | — | $93M |
| 2213 | Milestone Pharmaceuticals Inc. | — | $91M |
| 2214 | BE COOL PHARMACEUTICS, LLC | — | — |
| 2215 | Xeris Pharmaceuticals, Inc. | — | $80M |
| 2216 | Avenzo Therapeutics | — | $79M |
| 2217 | Oragenics, Inc. | — | $67M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.